193 related articles for article (PubMed ID: 34227028)
1. DNMT1 Mediated CAHM Repression Promotes Glioma Invasion via SPAK/JNK Pathway.
Xu Y; Li Z; Huai T; Huo X; Wang H; Bian E; Zhao B
Cell Mol Neurobiol; 2022 Nov; 42(8):2643-2653. PubMed ID: 34227028
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
3. CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia.
Pedersen SK; Mitchell SM; Graham LD; McEvoy A; Thomas ML; Baker RT; Ross JP; Xu ZZ; Ho T; LaPointe LC; Young GP; Molloy PL
Epigenetics; 2014 Aug; 9(8):1071-82. PubMed ID: 24799664
[TBL] [Abstract][Full Text] [Related]
4. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
Quan J; Ma C
Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
[TBL] [Abstract][Full Text] [Related]
5. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
[TBL] [Abstract][Full Text] [Related]
6. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
Gömöri E; Pál J; Kovács B; Dóczi T
Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
[TBL] [Abstract][Full Text] [Related]
7. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.
Bian EB; Ma CC; He XJ; Wang C; Zong G; Wang HL; Zhao B
Oncotarget; 2016 May; 7(21):30610-25. PubMed ID: 27121316
[TBL] [Abstract][Full Text] [Related]
9. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
[TBL] [Abstract][Full Text] [Related]
11. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
[TBL] [Abstract][Full Text] [Related]
12. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
Luo L; Chen C; He H; Cai M; Ling C
Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
Wu D; Sun J; Wang H; Ma C
Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
[TBL] [Abstract][Full Text] [Related]
15. TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.
Bao MH; Lv QL; Szeto V; Wong R; Zhu SZ; Zhang YY; Feng ZP; Sun HS
J Cell Physiol; 2020 May; 235(5):4594-4604. PubMed ID: 31637708
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NEAT1 promotes progression of glioma as a ceRNA by sponging miR-185-5p to stimulate DNMT1/mTOR signaling.
Yu H; Xu A; Wu B; Wang M; Chen Z
J Cell Physiol; 2021 Jan; 236(1):121-130. PubMed ID: 32803763
[TBL] [Abstract][Full Text] [Related]
18. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
[TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489.
Xu D; Liu R; Meng L; Zhang Y; Lu G; Ma P
Biomed Pharmacother; 2018 Apr; 100():20-28. PubMed ID: 29421578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]